Drug Pricing

Reshaping the PBM, Payer Relationship Could Improve Access to Care

March 4, 2024 - Pharmacy benefit managers (PBMs) and health insurers have significant influence on prescription drug costs and, as a result, on access to care, but the traditional model for this relationship may not support affordability.  PBMs were designed to alleviate payers of the responsibility of coordinating with pharmaceutical manufacturers. While the services that PBMs provide are...


More Articles

AHA Looks for More 340B Drug Pricing Enforcement

by Sara Heath

The American Hospital Association lead a cohort of five industry organizations to call for 340B drug pricing enforcement, as two US Courts of Appeals heart cases on the matter. Elsewhere in the...

Drug Prices Continue to Increase Costs for Consumers; Low-Value Care Study Raises AHA’s Ire

by Kyle Murphy, PhD

Happy Tuesday as warm temps and dry skies seem to be in the forecast for many of us. JAMA Study Finds 15% Increase in Out-of-Pocket Costs for Branded Drugs A JAMA study found that for 53.7% of...

Addressing the Drug Cost Challenge; Big Data Combats Rural Health Gaps

by Jacqueline LaPointe

Healthcare has faced longstanding challenges with prescription drug costs, health inequities, and care fragmentation. Organizations from across the care continuum are now leveraging capabilities, such...

Do Not Sell or Share My Personal Information
©2012-2024 TechTarget, Inc. Xtelligent Healthcare Media is a division of TechTarget. All rights reserved. HealthITAnalytics.com is published by Xtelligent Healthcare Media a division of TechTarget.